ANTI-HYPERGLYCEMIC ACTIVITY OF TOTAL ETHANOLIC FRUIT EXTRACT OF FAIDHERBIA ALBIDA ON NICOTINAMIDE-STREPTOZOTOCIN-INDUCED DIABETIC MICE | ||
| Bulletin of Pharmaceutical Sciences Assiut University | ||
| Article 4, Volume 44, Issue 1, June 2021, Pages 41-48 PDF (408.44 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/bfsa.2021.174126 | ||
| Authors | ||
| Rania A. Abdel-Emam1; Marwa M. Mohammed2; Ahmed A. Ali2; Ezz-eldin K. Desoky2; Lourin G. Malak2 | ||
| 1Department of Pharmacology, Faculty of Medicine, Assiut University, Assiut 71515, Egypt | ||
| 2Department of Pharmacognosy, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt | ||
| Abstract | ||
| Faidherbia albida is one of the plants that have been traditionally used throughout the world in the treatment of diabetes. In previous studies, various parts of the plant such as the methanolic root bark, aqueous seed, and the aqueous stem bark extracts have been tested on alloxan-induced diabetic rats for their anti-hyperglycemic activity. In the current study, the anti-hyperglycemic activity of the total ethanolic extract of Faidherbia albida fruits was evaluated in nicotinamide-streptozotocin-induced diabetic mice using glimepiride as a reference anti-diabetic drug. The total ethanolic fruit extract at 200 mg/kg body weight significantly (p < 0.05) lowered the blood glucose level in diabetic mice by (74%) after 4 hrs of oral administration while the peak hypoglycemic effect of glimepiride (55.2%) occurred at the 4th hr after oral administration. The results provided evidence that Faidherbia albida fruit extract is recommended to be used as a hypoglycemic drug in treating diabetic patients. | ||
|
Statistics Article View: 331 PDF Download: 556 |
||
